CQDM’s mission is to fund the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. To generate strong financial leverage and support high-risk high-reward projects, CQDM implemented a collaborative approach where Canadian and international partners fund biopharmaceutical research.

Together, they have already co-funded several projects of mutual interest. To date, partners have dedicated $100M in co-financing to biopharmaceutical research projects led by CQDM.

Biopharmaceutical research co-funding partners create synergies and promote collaborations between scientists and organizations across various disciplines. They pave the way to national and international contributions, while investing in research of mutual interest with CQDM.

Furthermore, biopharmaceutical research co-funding partners provide CQDM with complementary expertise, including such fields as:

• research in neurosciences, oncology and glycomics;
• company start-ups and funding;
• training of students and highly skilled personnel.